The Government of Canada has become the first country in the world to license a plant-based COVID-19 vaccine.
Canadian regulators said on February 24 that Medicago’s double-dose vaccine was approved for adults aged 18-64 years. There is not enough data to provide to adults over the age of 65. Officials said..
In a clinical trial cited by Health Canada, the vaccine is 71% effective for symptomatic treatment and 100% effective for severe symptoms associated with COVID-19 caused by the CCP (Chinese Communist Party) virus. I understand.
“These studies were conducted while multiple variants were in circulation,” Health Canada claimed. “The data suggest efficacy against multiple variants, including delta. Clinical trials with covifens have shown efficacy against delta and gamma variants, and data are against alpha, lambda, and mu variants. It also suggests effectiveness. “
The vaccine added by the authorities appears to produce neutralizing antibodies against Omicron, the world’s predominant strain.
“Health Canada has set conditions for approval,” said a Canadian agency. “Medicago must continue to provide Health Canada with information on the safety and efficacy of vaccines, which protects against current and emerging mutants of concern as they become available. Also included. “
He went on to say, “Based on data reviewed by Health Canada, the vaccine is approved for use in adults aged 18-64 years. The majority of older people are already vaccinated, so 65 years old. These participants had limited enrollment in clinical trials. Medicago is currently collecting data on older people to support regulatory approvals for this age group. “
The Covifenz brand homemade vaccine is based on a technology that uses plants in the development process to produce non-infectious particles that mimic the virus. Medicago plans to test the shot as a booster effect, and among the children, Medicago official Mark Andre Dorst told Reuters.
According to Canadian Press, Medicago vaccines use products that do not contain animal foods. We also use recombination technology that includes the gene sequence of a virus that uses a living plant as a host.
According to the report, virus-like particles mimic the shape and dimensions of the virus, allowing the human immune system to provoke a reaction.
The Government of Canada, which has been criticized for several weeks on how authorities have dealt with widespread truck driver protests, has approved several vaccines, including ones based on Moderna and Pfizer’s mRNA technology.
Last week, the country cleared a protein-based shot of Nuvavax for use in adults. Medicago will apply for approval for injections in Japan and is in talks with the US government and European and Asian regulators on the vaccine, Dorst said.
Reuters contributed to this report.
follow
Jack Phillips is the latest news reporter for The Epoch Times, based in New York.